Franklin Resources Inc. Acquires 7,625 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Franklin Resources Inc. increased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 65.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,333 shares of the medical instruments supplier’s stock after purchasing an additional 7,625 shares during the quarter. Franklin Resources Inc. owned 0.08% of ICU Medical worth $3,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of ICUI. Alliancebernstein L.P. boosted its holdings in ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock worth $4,051,000 after purchasing an additional 136 shares during the last quarter. O Shaughnessy Asset Management LLC purchased a new position in shares of ICU Medical in the 4th quarter worth $249,000. Pictet Asset Management Holding SA grew its holdings in shares of ICU Medical by 11.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 3,287 shares of the medical instruments supplier’s stock worth $510,000 after acquiring an additional 346 shares during the period. New Age Alpha Advisors LLC purchased a new stake in ICU Medical during the fourth quarter valued at $578,000. Finally, Norges Bank bought a new position in ICU Medical in the fourth quarter valued at about $40,151,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Trading Up 3.0 %

Shares of NASDAQ:ICUI opened at $142.65 on Friday. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The company has a market cap of $3.50 billion, a PE ratio of -31.21 and a beta of 0.86. The stock has a 50 day moving average of $148.29 and a 200 day moving average of $160.95. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ICUI shares. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday, April 4th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, ICU Medical currently has a consensus rating of “Buy” and an average price target of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.